Miracle surgery saves man with rare brain bubble at NYU Langone

The FDA is paus­ing pa­tient en­roll­ment and screen­ing for Nurix Ther­a­peu­tics’ Phase I clin­i­cal tri­al for a po­ten­tial drug to treat B-cell ma­lig­nan­cies in can­cer

Re­peat biotech founder Alex­is Borisy will have to give up at least two of his pub­lic board seats with­in a year, since the in­vestor is

Share this article By coupling the alpha particle emitting radioisotopes to tumour-selective carrier molecules, cancer cells can be targeted while leaving healthy cells alone. Image